Factors influencing time between biopsy and definitive surgery for malignant melanoma: do they impact clinical outcome?

American Journal of Surgery

Volumn 196, Issue 6, 2008, Pages 834-843

  Carpenter, Susanne ^a   Pockaj, Barbara ^a   Dueck, Amylou ^a   Gray, Richard ^a   Kurtz, David ^a   Sekulic, Aleksander ^a   Casey, William ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biopsy; Delay; Primary melanoma; Prognosis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; EXCISION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS; YOUNG ADULT;

EID: 57449094952     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.07.044     Document Type: Article

References (30)

1. Jemal A., Siegal R., Ward E., et al. Cancer statistics, 2006. CA Cancer. J Clin 56 (2006) 106-130
2. McKenna D.B., Lee R.J., Prescott R.J., et al. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision. Br J Dermatol 150 (2004) 523-530
3. Morton D., Thompson J., Cochran A., et al. Sentinel-node biopsy of Nodal observation in melanoma. N Engl J Med Sept 335 (2006) 1307-1317
4. Balch C.M., Buzaid A.C., Atkins M.B., et al. A new AJCC staging system for cutaneous melanoma. Cancer 88 (2000) 1484-1491
5. Balch C., Soong S., Gershenwald J., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma staging system. J Clin Oncol 19 (2001) 3622-3634
6. Francken A., Shaw H., Thompson J., et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 11 (2004) 426-433
7. Attis M.G., and Vollmer R.T. Mitotic rate in melanoma: a reexamination. Am J Clin Pathol 127 (2007) 380-384
8. Azzola M.F., Shaw H.M., Thompson J.F., et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 97 (2003) 1488-1498
9. Balch C.M., Buzaid A.C., Soon S.-J., et al. Final version of the AJCC staging system for cutaneous melanoma. J Clin Oncol 19 (2001) 3635-3648
10. Austin P.F., Cruse C.W., Lyman G., et al. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol 1 (1994) 487-494
11. McKenna D.B., Lee R.J., Prescott R.J., et al. The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival. Br J Dermatol 147 (2002) 48-54
12. Molenkamp B., Sluijter B., Oosterhof B., et al. Non-radical diagnostic biopsies do not negatively influence melanoma patient survival. Ann Surg Oncol 14 (2005) 1424-1430
13. Bong J.L., Herd R.M., and Hunger J.A. Incisional biopsy and melanoma prognosis. J Am Acad Dermatol 46 (2002) 690-694
14. Martin R.C., Scoggins C.R., Ross M.I., et al. Is incisional biopsy of melanoma harmful?. Am J Surg 190 (2005) 913-917
15. Diagnosis and treatment of early melanoma. NIH Consensus Development Conference January 27-29. Consens Statement 10 (1992) 1-25
16. Leiter U., Meier F., Schittek B., et al. The natural course of cutaneous melanoma. J Surg Oncol 86 (2004) 172-178
17. Yee V., Thompson J.F., McKinnon G., et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 12 (2005) 1-11
18. Dalal K.M., Patel A., Brady M.S., et al. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy. Ann Surg Oncol 14 (2006) 1934-1942
19. Richards M.A., Westcombe A.M., Love S.B., et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353 (1999) 1119-1126
20. Richards M.A., Smith P., Ramirez A.J., et al. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79 (1999) 858-864
21. Korsgaard M., Pedersen L., Sorensen H.T., et al. Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer. Cancer Detect Prev 30 (2006) 341-346
22. Halpern M.T., Bian J., Ward E.M., et al. Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer 110 (2007) 403-411
23. Committee on the Consequences of Uninsurance, Board on Health Care Services, Institute of Medicine. Care without coverage: too little, too late (2002), National Academy, Washington, DC
24. Scoggins C., Ross M., Reintgen D., et al. Gender-related differences in outcome for melanoma patients. Ann Surg 243 (2006) 693-700
25. Garbe C., Buttner P., Bertz J., et al. Primary cutaneous melanoma: identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 75 (1995) 2484-2491
26. Lasithiotakis K., Leiter U., Meier F., et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 112 (2008) 1795-1804
27. Sassen S., Shaw H.M., Colman M.H., et al. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center. Ann Surg Oncol 15 (2008) 630-637
28. Amersi F., and Morton D. The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg 41 (2007) 241-256
29. Garrison M., and Nathanson L. Prognosis and staging in melanoma. Semin Oncol 23 (1996) 725-733
30. Slingluff C.L., Stidham K.R., Ricci W.M., et al. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4,682 patients. Ann Surg 219 (1994) 120-130